GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (OTCPK:INNPF) » Definitions » Total Long-Term Liabilities

INNPF (InnoCan Pharma) Total Long-Term Liabilities : $1.30 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is InnoCan Pharma Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. InnoCan Pharma's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was $1.30 Mil.

InnoCan Pharma Total Long-Term Liabilities Historical Data

The historical data trend for InnoCan Pharma's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Total Long-Term Liabilities Chart

InnoCan Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial - - 0.02 0.01 -

InnoCan Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - - - 1.30

InnoCan Pharma Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

InnoCan Pharma Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (OTCPK:INNPF) » Definitions » Total Long-Term Liabilities
Comparable Companies
XCNQ:QNTM TSXV:LSL XCNQ:FNT.U TSXV:HASH XCNQ:LEEF TSXV:DB XCNQ:AYR.A NEOE:CBST TSXV:ZYUS XCNQ:IAN ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
IP4:Germany INNO:Canada
Address
1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7
Website
https://www.innocanpharma.com
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.